Guest: Antonio Inarejos García, Ph.D., R&D Manager, Pharmactive
The study was performed by Amanda Rao (RDC Global – Brisbane). The aim of this study is to understand the absorption of Affron® into the plasma. Little work has been done on the absorption and pharmacokinetics of saffron and its constituents. This study will help to understand how quickly Affron® is absorbed into the plasma and its metabolism in the body.
A randomized clinical trial to determine the efficacy of Affron®, a standardized extract of Saffron (Crocus sativus) on mood and cognitive function in healthy adults over 4 weeks. (Amanda Rao). Published.
Efficacy of Curcumin, and a Saffron/ Curcumin Combination for the Treatment of Major Depression: A Randomized, Double-Blind, Placebo-Controlled Study Journal of Affective Disorders, October 2016
Saffron for the treatment of adolescent depressive and anxiety symptoms – a randomized, double-blind, placebo-controlled study (Adrian Lopresti – Peter Drummond) study finalized but not published yet.
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372113&isReview=true
Affron® Absorption and pharmacokinetic study (starting july 2017)